Norditropin for female infertility
Record ID 32013000196
English
Authors' recommendations:
Recombinant human growth hormone has been used as an adjunctive treatment for female infertility in women undergoing ovarian stimulation protocols that may or may not be part of in vitro fertilization procedures. The goal of these treatments is to enhance the ovarian response to hormonal stimulation and ultimately to increase the rates of pregnancies and live births.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
The report may be purchased from:http://www.hayesinc.com/hayes/crd/?crd=14689
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Infertility, Female
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.